Rossari Biotech Ltd.

•

rossari.comBSE: 543213NSE: ROSSARI

Market Cap₹ 2,478 Cr.

Current Price

High / Low₹ 690 / 375

Stock P/E16.4

Book Value₹ 246

Price to Book1.58

Dividend Yield0.11 %

ROCE14.8 %

ROE11.9 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Company has consistently been profitable over the last 5 years
Company has delivered good sales growth of 27.6% CAGR over last 5 years
Working capital cycle has improved - days down from 88 to 68
Stock looks reasonably valued - P/E of 16.4 is below its historical median
Company comfortably covers its interest (8.1x coverage)
Company has a consistent dividend-paying track record

CONS

Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.59x)
Free cash flow has been persistently negative
Total debt has risen sharply - up 117.0% year on year
Though reporting repeated profits, the company pays out little dividend (1.9%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SOLARINDS	22307.50	101.37	201860.69	0.05	666.37	88.98	3668.20	70.26	38.16	27.91
2.	PIDILITIND	1567.45	60.23	159547.55	1.37	8835.10	1202.86	45515.50	1112.74	32.38	26.28
3.	SRF	2483.00	34.05	73602.28	0.36	758.87	75.53	5033.26	34.63	14.21	24.57
4.	FLUOROCHEM	4771.75	85.23	52417.67	0.06	219.00	19.02	1588.00	23.97	9.58	26.83
5.	NAVINFLUOR	8541.10	55.49	43822.77	0.18	243.31	107.67	1045.08	44.07	21.39	34.17
6.	GODREJIND	1127.00	32.29	37963.11	0.00	523.36	-27.85	5448.09	22.16	10.64	12.82
7.	AETHER	1672.95	94.41	22204.70	0.00	62.75	33.45	326.56	27.49	11.65	31.47
8.	DEEPAKNTR	1587.10	27.64	21646.94	0.47	345.01	207.36	2577.60	36.39	11.58	20.96
9.	ATUL	6244.55	23.11	18385.05	0.48	253.93	91.85	1847.95	25.03	15.05	21.41
10.	AARTIIND	492.15	33.62	17851.59	0.20	155.00	260.47	2387.00	42.42	6.95	16.00
11.	DEEPAKFERT	1320.45	17.00	16725.20	0.76	490.04	100.95	3256.26	22.47	12.12	25.96
12.	ROSSARI	447.40	16.44	2478.33	0.11	35.09	4.46	697.20	28.23	14.84	11.63

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	411	483	464	473	490	498	513	580	544	586	582	685	697
	353	420	400	409	425	432	448	510	476	514	513	608	653
Operating Profit	58	64	64	64	65	66	65	69	68	72	69	77	44
OPM %	14.06%	13.15%	13.73%	13.45%	13.25%	13.23%	12.63%	11.99%	12.48%	12.27%	11.84%	11.28%	6.31%
	2	1	4	0	1	1	1	2	1	2	1	19	3
Interest	6	5	4	3	4	4	5	6	6	6	8	9	11
Depreciation	14	15	15	16	15	15	18	18	18	18	20	24	26
Profit before Tax	40	45	48	45	47	48	42	48	46	49	42	64	48
Tax %	25.92%	26.48%	28.04%	25.20%	25.84%	26.73%	25.40%	27.88%	27.42%	26.02%	23.11%	28.68%	26.38%
Net Profit	0	0	0	0	35	35	32	34	34	37	33	46	35
	5.30	5.97	6.23	6.18	6.32	6.39	5.73	6.22	6.07	6.66	5.92	8.30	6.34

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	233	292	516	600	709	1,483	1,656	1,831	2,080	2,396	2,550
	209	247	439	495	586	1,307	1,441	1,587	1,826	2,127	2,288
Operating Profit	24	45	78	105	123	176	215	243	254	269	262
OPM %	10.43%	15.30%	15.02%	17.45%	17.35%	11.89%	12.96%	13.28%	12.22%	11.23%	10.28%
	1	1	1	4	9	19	14	14	15	39	24
Interest	2	1	3	4	3	13	22	19	18	29	34
Depreciation	4	5	12	17	23	48	63	60	67	79	87
Profit before Tax	19	40	63	88	107	136	144	178	185	203	203
Tax %	16.89%	26.64%	27.94%	25.71%	25.08%	28.31%	25.63%	26.42%	26.36%	26.32%	26.34%
Net Profit	16	29	46	65	80	98	107	131	136	149	149
EPS	35.75	65.94	9.44	13.23	15.47	17.70	19.38	23.66	24.63	26.94	—
Dividend Payout %	0.00%	30.33%	4.82%	3.89%	3.24%	2.82%	2.57%	2.11%	2.03%	1.86%	—

COMPOUNDED SALES GROWTH

10 Years:: 30%
5 Years:: 28%
3 Years:: 13%

COMPOUNDED PROFIT GROWTH

10 Years:: 46%
5 Years:: 13%
3 Years:: 12%

STOCK PRICE CAGR

10 Years:: —
5 Years:: -20%
3 Years:: -19%
1 Year:: -30%

RETURN ON EQUITY

10 Years:: 23%
5 Years:: 13%
3 Years:: 12%
Last Year:: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	4	4	10	10	11	11	11	11	11
	61	90	119	276	396	791	901	1,033	1,172	1,317
	22	23	4	61	0	85	72	107	198	398
Trade Payables	32	40	106	97	131	186	181	219	286	323
	5	8	49	80	107	344	407	455	520	605
Total Liabilities	124	166	283	525	645	1,417	1,572	1,825	2,187	2,655
	38	45	74	94	181	607	585	578	598	784
Capital Work in Progress	8	10	3	22	0	1	13	47	140	173
	0	7	0	18	0	36	51	63	84	62
	24	35	55	58	95	190	188	282	355	405
	0	0	0	0	0	0	0	425	475	557
Cash & Bank	2	1	6	127	88	52	124	30	57	92
	52	68	145	206	280	530	610	399	478	580
Total Assets	124	166	283	525	645	1,417	1,572	1,825	2,187	2,655

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	10	34	92	77	79	79	199	43	137	65
Cash from Investing	-6	-20	-36	-190	-37	-299	-181	-103	-184	-219
Cash from Financing	-2	-5	-29	157	-25	292	61	16	65	186
	-0	-2	6	23	-14	22	32	-44	19	32

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	68.32	68.27	68.19	68.18	68.17	68.17	68.16	68.15	68.14
	3.83	3.74	3.74	3.98	3.48	2.70	2.32	2.18	2.03
	16.87	17.34	17.47	17.59	17.84	18.18	18.25	18.21	14.64
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	10.98	10.65	10.60	10.25	10.51	10.95	11.26	11.46	15.20

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

2026-08-06

Updates

2026-08-06 - Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.

2026-08-03

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

2026-07-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-24 - Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.

2026-07-20

Shareholders meeting

2026-07-20 - Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.

2026-07-20

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-20 - Audio recording of Earnings Conference Call for Q1 FY 27.

2026-07-20

ESOP/ESOS/ESPS

2026-07-20 - Update on Grant of Options

2026-07-19

Press Release

2026-07-19 - Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled " Rossari Biotech announces Q1 FY 27 results".

2026-07-19

Investor Presentation

2026-07-19 - Rossari Biotech Limited has informed the Exchange about Investor Presentation

News

Recent coverage and analyst commentary for ROSSARI

Loading news…

🤖

AI Stock Analyst

Rossari Biotech Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account